XLRN

Acceleron Pharma Inc.
XLRN

Overview Fund Activity
Delisted

XLRN was delisted on the 19th of November, 2021.

Back to rankings

115 hedge funds and large institutions have $956M invested in Acceleron Pharma Inc. in 2015 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 40 increasing their positions, 31 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
115
Holders Change
+5
Holders Change %
+4.55%
% of All Funds
3.07%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.13%
New
21
Increased
40
Reduced
31
Closed
15
Calls
$5.99M
Puts
$6.99M
Net Calls
-$1M
Net Calls Change
-$7.02M

Top Buyers

1
ORI
1
Oak Ridge Investments
Illinois
$44.2M
2
PC
2
PointState Capital
New York
$18.1M
3
GIM
3
Granahan Investment Management
Massachusetts
$17.9M
4
Lord, Abbett & Co
4
Lord, Abbett & Co
New Jersey
$14.5M
5
Brown Advisory
5
Brown Advisory
Maryland
$10.2M

Top Sellers

1
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$45.7M
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$121M
3
QF
3
QVT Financial
New York
$29M
4
PVMCI
4
Polaris Venture Management Co IV
Massachusetts
$91.2M
5
DCM
5
Driehaus Capital Management
Illinois
$2.2M
Name Holding Trade Value Shares
Change 		Shares
Change %
PAM
126
Panagora Asset Management
Massachusetts
– -$40K -1,027 Closed
QT
127
Quantbot Technologies
New York
– -$39K -1,024 Closed
TC
128
Travelers Companies
Minnesota
– -$33K -838 Closed
SFU
129
Stonehage Fleming (UK)
United Kingdom
– -$20K -518 Closed
MAA
130
Managed Account Advisors
New Jersey
– -$1K -28 Closed
2 3 4 5
6